-
1
-
-
21744438918
-
Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status
-
Furuta T, Shirai N, Sugimoto M, Nakamura A, Okudaira K, Kajimura M, Hishida A: Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status. Aliment Pharmacol Ther 2005;22:67-74.
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 67-74
-
-
Furuta, T.1
Shirai, N.2
Sugimoto, M.3
Nakamura, A.4
Okudaira, K.5
Kajimura, M.6
Hishida, A.7
-
2
-
-
0021060508
-
Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release
-
Londong W, Londong V, Cederberg C, Steffen H: Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology 1983;85:1373-1378.
-
(1983)
Gastroenterology
, vol.85
, pp. 1373-1378
-
-
Londong, W.1
Londong, V.2
Cederberg, C.3
Steffen, H.4
-
3
-
-
0031700062
-
Nocturnal gastric acidity and breakthrough on different regimens of omeprazole 40 mg daily
-
Hatlebakk JG, Katz PO, Kuo B, Castell DO: Nocturnal gastric acidity and breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther 1998;12:1235-1240.
-
(1998)
Aliment Pharmacol Ther
, vol.12
, pp. 1235-1240
-
-
Hatlebakk, J.G.1
Katz, P.O.2
Kuo, B.3
Castell, D.O.4
-
5
-
-
42049114160
-
4 selective agonist, beneficially affects pharmacokinetics of proton pump inhibitor
-
4 selective agonist, beneficially affects pharmacokinetics of proton pump inhibitor. Gastroenterology 2005;128:A531.
-
(2005)
Gastroenterology
, vol.128
-
-
Takeuchi, Y.1
Watanabe, H.2
Imawari, M.3
-
6
-
-
0029977698
-
Pharmacokinetics, metabolism and interactions of acid pump inhibitors
-
Anderson T: Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Clin Pharmacokinet 1996;31:9-28.
-
(1996)
Clin Pharmacokinet
, vol.31
, pp. 9-28
-
-
Anderson, T.1
-
9
-
-
0035894575
-
Serotoninergic neuroenteric modulators
-
Talley NJ: Serotoninergic neuroenteric modulators. Lancet 2001;358:2061-2068.
-
(2001)
Lancet
, vol.358
, pp. 2061-2068
-
-
Talley, N.J.1
-
10
-
-
0026093583
-
Prokinetic effect of AS-4370 on gastric emptying in healthy adult
-
Kanazumi T, Nakano H, Matsui Y, Ishikawa H, Shimizu R, Park S, Kuriya N: Prokinetic effect of AS-4370 on gastric emptying in healthy adult. Eur J Clin Pharm 1991;41:335-337.
-
(1991)
Eur J Clin Pharm
, vol.41
, pp. 335-337
-
-
Kanazumi, T.1
Nakano, H.2
Matsui, Y.3
Ishikawa, H.4
Shimizu, R.5
Park, S.6
Kuriya, N.7
-
11
-
-
0036859838
-
Influence of mosapride citrate on gastric motility and autonomic nervous function
-
Endo J, Nomura M, Morishita S, Uemura N, Inoue S, Kishi S, Kawaguchi R, Iga A, Nakaya Y: Influence of mosapride citrate on gastric motility and autonomic nervous function. J Gastroenterol 2002;37:888-895.
-
(2002)
J Gastroenterol
, vol.37
, pp. 888-895
-
-
Endo, J.1
Nomura, M.2
Morishita, S.3
Uemura, N.4
Inoue, S.5
Kishi, S.6
Kawaguchi, R.7
Iga, A.8
Nakaya, Y.9
-
12
-
-
0034819828
-
Effect of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin
-
Itoh H, Nagago T, Takeyama M: Effect of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin. Biol Pharm Bull 2001;24:1072-1075.
-
(2001)
Biol Pharm Bull
, vol.24
, pp. 1072-1075
-
-
Itoh, H.1
Nagago, T.2
Takeyama, M.3
-
13
-
-
0032807774
-
Review article: Cytochrome P450 and the metabolism of proton pump inhibitors - emphasis on rabeprazole
-
Ishizaki T, Horai Y: Review article: cytochrome P450 and the metabolism of proton pump inhibitors - emphasis on rabeprazole. Aliment Pharmacol Ther 1999;13:27-36.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 27-36
-
-
Ishizaki, T.1
Horai, Y.2
-
14
-
-
0642379417
-
Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors
-
Kita T, Sakaeda T, Baba T, Aoyama N, Kakumoto M, Kurimoto Y, Kawahara Y, Okamura N, Kirita S, Kasuga M, Okumura K: Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors. Biol Pharm Bull 2003;26:386-390.
-
(2003)
Biol Pharm Bull
, vol.26
, pp. 386-390
-
-
Kita, T.1
Sakaeda, T.2
Baba, T.3
Aoyama, N.4
Kakumoto, M.5
Kurimoto, Y.6
Kawahara, Y.7
Okamura, N.8
Kirita, S.9
Kasuga, M.10
Okumura, K.11
-
15
-
-
0034990069
-
Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotype
-
Horai Y, Kimura M, Furuie H, Matsuguma K, Irie S, Koga Y, Nagahama T, Murakami M, Matsui T, Yao T, Urae A, Ishizaki T: Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotype. Aliment Pharmacol Ther 2001;15:793-803.
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 793-803
-
-
Horai, Y.1
Kimura, M.2
Furuie, H.3
Matsuguma, K.4
Irie, S.5
Koga, Y.6
Nagahama, T.7
Murakami, M.8
Matsui, T.9
Yao, T.10
Urae, A.11
Ishizaki, T.12
-
16
-
-
4744342555
-
Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to P450 2C19 genotype status
-
Sugimoto M, Furuta T, Shirai N, Kajimura M, Hishida A, Sakurai M, Ohashi K, Ishizaki T: Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to P450 2C19 genotype status. Clin Pharmacol Ther 2004;76:290-301.
-
(2004)
Clin Pharmacol Ther
, vol.76
, pp. 290-301
-
-
Sugimoto, M.1
Furuta, T.2
Shirai, N.3
Kajimura, M.4
Hishida, A.5
Sakurai, M.6
Ohashi, K.7
Ishizaki, T.8
-
17
-
-
1542573393
-
Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in Japanese population
-
Fukushima-Uesaka H, Saito Y, Watanabe H, et al: Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in Japanese population. Hum Mutations 2004;23:100.
-
(2004)
Hum Mutations
, vol.23
, pp. 100
-
-
Fukushima-Uesaka, H.1
Saito, Y.2
Watanabe, H.3
-
18
-
-
33746446370
-
Effect of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes
-
Shimizu M, Uno T, Yasui-Furukori N, Sugawara K, Tateishi T: Effect of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes. Eur J Clin Pharmacol 2006;62:597-603.
-
(2006)
Eur J Clin Pharmacol
, vol.62
, pp. 597-603
-
-
Shimizu, M.1
Uno, T.2
Yasui-Furukori, N.3
Sugawara, K.4
Tateishi, T.5
-
19
-
-
0036432798
-
The clinical importance of proton pump inhibitor pharmacokinetics
-
Yacyshyn BR, Thomson ABR: The clinical importance of proton pump inhibitor pharmacokinetics. Digestion 2002;66:67-78.
-
(2002)
Digestion
, vol.66
, pp. 67-78
-
-
Yacyshyn, B.R.1
Thomson, A.B.R.2
-
20
-
-
12344321002
-
Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: A randomized trial
-
Madan K, Ahuja V, Kashyap PC, Sharma P: Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. Dis Esophagus 2004;17:274-278.
-
(2004)
Dis Esophagus
, vol.17
, pp. 274-278
-
-
Madan, K.1
Ahuja, V.2
Kashyap, P.C.3
Sharma, P.4
-
21
-
-
42049120978
-
Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy
-
Miyamoto M, Haruma K, Takeuchi K, Kuwabara M: Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy. J Gastroenterol Hepatol 2007;23:746-751.
-
(2007)
J Gastroenterol Hepatol
, vol.23
, pp. 746-751
-
-
Miyamoto, M.1
Haruma, K.2
Takeuchi, K.3
Kuwabara, M.4
-
22
-
-
0030801806
-
Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: Implications for proarrhythmic potential?
-
Carlsson L, Amos GJ, Andersson B, Drews L, Duker G, Wadstedt G: Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential? J Pharmacol Exp Ther 1997;282:220-227.
-
(1997)
J Pharmacol Exp Ther
, vol.282
, pp. 220-227
-
-
Carlsson, L.1
Amos, G.J.2
Andersson, B.3
Drews, L.4
Duker, G.5
Wadstedt, G.6
-
23
-
-
34548528046
-
Treatment of functional dyspepsia with serotonin agonist: A meta-analysis of randomized controlled trials
-
Hiyama T, Yoshihara M, Matuo K, Kusunoki H, Kamada T, Ito M, Tanaka S, Chayama K, Haruma K: Treatment of functional dyspepsia with serotonin agonist: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2007;22:1566-1570.
-
(2007)
J Gastroenterol Hepatol
, vol.22
, pp. 1566-1570
-
-
Hiyama, T.1
Yoshihara, M.2
Matuo, K.3
Kusunoki, H.4
Kamada, T.5
Ito, M.6
Tanaka, S.7
Chayama, K.8
Haruma, K.9
|